Participants were examined by a study doctor and chosen to be in the study if they:
 provided their informed consent
 were adults
 were newly diagnosed with multiple myeloma and had bone lesions in one or
more places
 had received treatment for multiple myeloma for no more than 30 days
 had received no more than 1 dose of bisphosphonate medicine by IV infusion
(in the vein)
 were able to walk and care for themselves
 had adequate organ function (body organs were working well enough)
5